Who owns Cullinan Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CGEM from SEC Form 13F filings across 182 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 182 institutions disclosed 70.1M shares of Cullinan Therapeutics, Inc. worth $1.08B — about 114% of shares outstanding; the largest disclosed holder is MPM BIOIMPACT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
182
13F holders
$1.08B
value, 2026 filers
114%
of shares outstanding (70.1M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CGEM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MPM BIOIMPACT LLC | 9.7M | $149.2M | 11.1% | 15.8% | -0.1% |
| 2 | Lynx1 Capital Management LP | 9.0M | $137.6M | 21.3% | 14.6% | 0.0% |
| 3 | BVF INC/IL | 5.8M | $88.3M | 2.9% | 9.4% | 0.0% |
| 4 | BlackRock, Inc. | 5.3M | $81.7M | 0.0% | 8.7% | +1.7% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.1M | $62.8M | 0.0% | 6.7% | +6.9% |
| 6 | Kynam Capital Management, LP | 3.1M | $47.8M | 2.6% | 5.1% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $40.5M | 0.0% | 4.3% | +1.1% |
| 8 | STATE STREET CORP | 2.6M | $40.0M | 0.0% | 4.2% | -29.0% |
| 9 | RTW INVESTMENTS, LP | 2.4M | $36.3M | 0.4% | 3.8% | 0.0% |
| 10 | Siren, L.L.C. | 1.8M | $27.5M | 0.7% | 2.9% | -5.3% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $22.2M | 0.0% | 2.4% | -6.4% |
| 12 | Blue Owl Capital Holdings LP | 1.4M | $21.5M | 3.9% | 2.3% | -9.1% |
| 13 | Venrock Adviser, LLC | 1.4M | $21.2M | 1.0% | 2.2% | 0.0% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $16.7M | 0.0% | 1.8% | +3.6% |
| 15 | GOLDMAN SACHS GROUP INC | 988,963 | $15.2M | 0.0% | 1.6% | -1.3% |
| 16 | Elmind Capital, LP | 962,792 | $14.8M | 3.7% | 1.6% | +39.5% |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 953,126 | $14.6M | 0.2% | 1.5% | -12.0% |
| 18 | Affinity Asset Advisors, LLC | 875,760 | $13.4M | 0.5% | 1.4% | 0.0% |
| 19 | Fisher Asset Management, LLC | 800,961 | $12.3M | 0.0% | 1.3% | +2125.0% |
| 20 | BOONE CAPITAL MANAGEMENT LLC | 690,814 | $10.6M | 2.8% | 1.1% | -1.9% |
| 21 | MORGAN STANLEY | 644,639 | $9.9M | 0.0% | 1% | +2.5% |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | 643,491 | $9.9M | 0.0% | 1% | -12.9% |
| 23 | TWIN FOCUS CAPITAL PARTNERS, LLC | 595,489 | $9.1M | 0.9% | 1% | 0.0% |
| 24 | NORTHERN TRUST CORP | 558,159 | $8.6M | 0.0% | 0.9% | -2.3% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 506,077 | $7.8M | 0.0% | 0.8% | +9.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.